Multigenerational VHL family characterized by pathogenic germline ELOC variant: Response to belzutifan
Cathy D. Vocke(National Cancer Institute), W. Marston Linehan(National Institutes of Health), Svetlana Pack(National Cancer Institute), Mark W. Ball(Johns Hopkins University), Maria J. Merino(National Institutes of Health), Mark Raffeld(National Cancer Institute), Alexandra Lebensohn(National Institutes of Health), Nityam Rathi(Cleveland Clinic), Ramaprasad Srinivasan(National Cancer Institute), Ashkan A. Malayeri(Genetics and IVF Institute), Rabindra Gautam(National Institutes of Health), Deborah Nielsen(National Institutes of Health), Emily Y. Chew(National Institutes of Health), Prashant Chittiboina(National Institutes of Health), C. Ricketts(National Cancer Institute), Lidenys O'Brien(National Institutes of Health), Mary Welch(Columbia University Irving Medical Center)
Urologic Oncology Seminars and Original Investigations
November 13, 2025
Cited by 4
Related Papers
Next-generation genotype imputation service and methods
|Nature Genetics|2016|4.5k
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818
Seven new loci associated with age-related macular degeneration
|Nature Genetics|2013|802
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
|Blood|2011|638
Gigantism and Acromegaly Due to Xq26 Microduplications and <i>GPR101</i> Mutation
|New England Journal of Medicine|2014|340